Background We measured the expression of some commonly used tumor markers with RNA
sequencing (RNA-Seq) to identify any that might be useful for the evaluation of squamous …

Background S100B is an astrocytic protein that enters the blood stream when there is
disruption of the blood-brain barrier (BBB). Over time, antibodies against S100B develop in …

Background: To evaluate the clinical utility of CA215 as a pan cancer biomarker, serum
levels of CA215 were determined with clinically defined serum specimens from over 500 …

The usefulness of tumor markers in non-small cell lung carcinoma (NSCLC) is not well
defined. The aim of this study was to determine the predictive value for response to …

CA125 is a heavily glycosylated protein and was first identified as an ovarian cancer antigen
in 1981 that is recognized by a monoclonal antibody generated by the hybridoma technique …

No evidence currently exists to demonstrate the prognostic value of serum carcinoembryonic
antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) in patients with unresectable …

Abstract Background and Aim: Serum cancer antigen (CA) 125 elevation has been reported
in patients with liver disease, but it is poorly characterized. The present study aimed to …

Widespread metastasis of hepatocellular carcinoma (HCC) was a complex cascade of
events, which is still beyond full appreciation. Screening key proteins, which play a critical …

Aim. Little is known about the association between cancer antigen 125 (MUC16/CA125)
concentrations and tumor diameter of patients with hepatocellular carcinoma (HCC) and low …

Objective To explore the value of serum neuron-specific enclose (NSE) before treatment in
predicting brain metastases and prognosis of advanced non-small cell lung cancer …